Abstract
Pheochromocytomas are tumors able to produce catecholamines and a variety of biologically active neuropeptides. We report the case of a 36-yr-old female patient with pheochromocytoma exhibiting headache, intermittent fever, thrombocytosis, and marked inflammatory signs. Nonsteroidal anti-inflammatory drugs were ineffective in lowering the body temperature, while a corticosteroid agent obtained excellent results. IL-6 was found elevated (20 pg/ml); it fell to 4.5 pg/ml 3 weeks after the adrenalectomy, in parallel to normalization of other laboratory data. The interleukin-6 (IL-6) over-production can either be ascribed directly to the tumor (as confirmed by immunohistochemistry) or indirectly accounted for by tumoral production, as a consequence of the high levels of circulating norepinephrine. To our knowledge, our paper represents the 6th case report of IL-6 secreting pheochromocytoma associated with clinical markers of inflammatory response.
Similar content being viewed by others
References
Forman B.H. ACTH-secreting pheochromocytoma. N. Engl. J. Med. 1979, 301: 1399.
White A., Ray D.W., Talbot A., Abraham P., Thody A.J., Bevan J.S. Cushing’s syndrome due to phaeochromocytoma secreting the precursors of adrenocorticotropin. J. Clin. Endocrinol. Metab. 2000, 85: 4771–4775.
Venihaki M., Gravanis A., Margioris A.N. KAT45 human pheochromocytoma cell line. A new model for the in vitro study of neuro-immuno-hormonal interactions. Ann. N. Y. Acad. Sci. 1998, 840: 425–433.
Boccara G., Mann C., Guillon G. Secretion of vasopressin from a human pheochromocytoma. Ann. Intern. Med. 1998, 128: 1049.
Goumon Y., Zhu W., Weeks B.S., et al. Identification of morphine in the adrenal medullary chromaffin PC-12 cell line. Brain Res. Mol. Brain Res. 2000, 81: 177–180.
Minamino N., Kangawa K., Matsua H. Adrenomedullin: a new peptidergic regulator of the vascular function. Clin. Hemorheol. Microcirc. 2000, 23: 95–102.
Saida K., Uchide T., Usui A., et al. The endothelin-2/vasoactive intestinal contractor gene: expression and promoter activity in PC12 rat pheochromocytoma cells. J. Cardiovasc. Pharmacol. 2000, 36: S9–11.
Takahashi K., Totsune K., Murakami O., et al. Expression of melanin-concentrating hormone receptor messenger ribonucleic acid in tumor tissues of pheochromocytoma, ganglioneuroblastoma, and neuroblastoma. J. Clin. Endocrinol. Metab. 2001, 86: 369–374.
Ohji H., Sasagawa I., Iciyanagi O., Suzuki Y., Nakada T. Tumour angiogenesis and Ki-67 expression in phaeochromocytoma. B.J.U. Int. 2001, 87: 381–385.
Drenou B., Le Tulzo Y., Caulet-Maugendre S., et al. Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion. Nouv. Rev. Fr. Hematol. 1995, 37: 197–199.
Rezkalla M.A., Rizk S.N., Ryan J.J. Pheochromocytoma associated with polycythemia: case report. S. D. J. Med. 1995, 48: 349–351.
Alheim K., Andersson C., Tingsborg S., Ziolkowska M., Schultzberg M., Bartfai T. Interleukin-1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells. Proc. Natl. Acad. Sci. U.S.A. 1991, 88: 9302–9306.
Bornstein S.R., Ehrhart-Bornstein M., Gonzalez-Hernandez J., Schroder S., Scherbaum W.A. Expression of interleukin- 1 in human pheochromocytoma. J. Endocrinol. Invest. 1996, 19: 693–698.
Alheim K., McDowell T.L., Symons J.A., Duff G.W., Bartfai T. An AP-1 site is involved in the NGF induction of IL-1 alpha in PC12 cells. Neurochem. Int. 1996, 29: 487–496.
Liu M.T., Huang H.M., Jeng K.C., Ou S.C., Kuo J.S. Induction of cytokine genes and IL-1alpha by chemical hypoxia in PC12 cells. Life Sci. 2000, 67: 2147–2157.
Fukumoto S., Matsumoto T., Harada S., Fujisaki J., Kawano M., Ogata E. Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin-6 production. J. Clin. Endocrinol. Metab. 1991, 73: 877–881.
Suzuki K., Miyashita A., Inoue Y., et al. Interleukin-6 producing pheochromocytoma. Acta Haematol. 1991, 85: 217–219.
Takagi M., Egawa T., Motomura T., et al. Interleukin-6 secreting phaeochromocytoma associated with clinical markers of inflammation. Clin. Endocrinol. 1997, 46: 507–509.
Salahuddin A, Rohr-Kirchgraber T, Shekar R, West B, Loewenstein J. Interleukin-6 in the fever and multiorgan crisis of pheochromocytoma. Scand. J. Infect. Dis. 1997, 29: 640–642.
Shimizu C., Kubo M., Takano K., et al. Interleukin-6 (IL-6) producing phaeochromocytoma: direct IL-6 suppression by non-steroidal anti-inflammatory drugs. Clin. Endocrinol. (Oxf.) 2001, 54: 405–410.
Marz P., Gadient R.A., Otten U. Expression of interleukin- 6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha). Brain Res. 1996, 706: 71–79.
Tirone F., Shooter E.M. Early gene regulation by nerve growth factor in PC12 cells: induction of an interferon-related gene. Proc. Natl. Acad. Sci. U.S.A. 1989, 86: 2088–2092.
Tsigos C., Papanicolaou D.A., Defensor R., Miiadis C.S., Kyrou I., Chrousos G.P. Dose Effects of Recombinant Human Interleukin-6 on Pituitary Hormone Secretion and Energy Expenditure. Neuroendocrinology 1997, 66: 54–62.
Papanicolaou D.A., Vgontzas A.N. Editorial: Interleukin-6: The Endocrine Cytokine. J. Clin. Endocrinol. Metab. 2000, 85: 1331–1333.
Chesnokova V., Melmed S. Minireview: Neuro-Immuno- Endocrine Modulation of the Hypothalamic-Pituitary- Adrenal Axis by gp130 Signaling Molecles. Endocrinology 2002, 143: 1571–1574.
Bastard J.P., Maachi M., Van Nhieu J.T., et al. Adipose Tissue IL-6Content Correlates with Resistance to Insulin Activation of Glucose Uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 2002, 87: 2084–2089.
Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Circadian Interleukin-6 Secretion and Quantità and Depth of Sleep. J. Clin. Endocrinol. Metab. 1999, 84: 2603–2607.
Tamura T., Udagawa N., Takahashi N., et al. Soluble interleukin- 6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 1993, 90: 11924–11928.
Path G., Bornstein S.R., Ehrhart-Bornstein M., Scherbaum W.A. Interleukin-6 receptor in the human adrenal gland: Expression and effects on steroidogenesis. J. Clin. Endocrinol. Metab. 1997, 82: 2343–2349.
Gonzalez-Hernandez J.A., Bornstein S.R., Ehrhart-Bornstein M., Spath-Schwalbe E., Jirikowski G., Scherbaum W.A. Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: New clue to a paracrine or autocrine regulation of adrenal function. J. Clin. Endocrinol. Metab. 1994, 79: 1492–1497.
Montero-Julian F.A. The soluble IL-6 receptors: serum levels and biological function. Cell Mol Biol 2001, 47: 583–597.
Ray A., Zhang D.H., Siegel M.D., Ray P. Regulation of interleukin- 6 gene expression by steroids. Ann. N.Y. Acad. Sci. 1995, 762: 79–87.
Hirano T., Taga T., Nakano N., et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. U.S.A. 1985, 82: 5490–5494.
Hirano T., Yasukawa K., Harada H., et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986, 324: 73–76.
Takizawa H., Narisawa R., Asakura H. Jejunal invasion of pheochromocytoma pathologically confirmed by endoscopic biopsy. Am. J. Med. Sci. 1999, 317: 63–66.
Sakai C., Takagi T., Oguro M., Wakatsuki S., Kuwahara T. Malignant pheochromocytoma accompanied by microangiopathic hemolytic anemia: a case report. Jpn. J. Clin. Oncol. 1994, 24: 171–174.
Johnson C.S., Cook C.A., Furmanski P. in vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). Exp. Hematol. 1990, 18: 109–113.
Fuchs D., Hausen A., Reibnegger G., et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur. J. Haematol. 1991, 46: 65–70.
Means R.T. Jr., Dessypris E.N., Krantz S.B. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J. Cell. Physiol. 1992, 150: 59–64.
Jovcic G., Ivanovic Z., Biljanovic-Paunovic L., Bugarski D., Stosic-Grujicic S., Milenkovic P. The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow. Leukemia 1996, 10: 564–569.
Allen D.A., Breen C., Yaqoob M.M., Macdougall I.C. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNFalpha. J. Investig. Med. 1999, 47: 204–211.
Casadevall N. Cellular mechanism of resistance to erythropoietin. Nephrol. Dial. Transplant. 1995, 10: S27–30.
Cazzola M., Ponchio L., de Benedetti F., et al. Defective Iron Supply for Erythropoiesis and Adequate Endogenous Erythropoietin Production in the Anemia Associated With Systemic-Onset Juvenile Chronic Arthritis. Blood 1996; 87: 4824–4830.
Plouin P.F., Chatellier G., Fofol I., Corvol P. Tumour recurrence and hypertension persistence after successfull phaeochromocytoma operation. Hypertension 1997, 29: 1133–1139.
Van der Harst E., de Krijger R.R., Bruining H.A., et al. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur. J. Endocrinol. 2002, 147: 85–94.
van Gool J., van Vugt H., Helle M., Aarden L.A. The Relation Among Stress, Adrenalin, Interleukin 6 and Acute Phase Proteins in the Rat. Clin. Immunol. Immunopathol. 1990, 57: 200–210.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Minetto, M., Dovio, A., Ventura, M. et al. Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome. J Endocrinol Invest 26, 453–457 (2003). https://doi.org/10.1007/BF03345202
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345202